Close Menu

NEW YORK – NeuMoDx Molecular announced on Wednesday that it has received the CE mark for its viral load monitoring assay.

In collaboration with Milan, Italy-based Sentinel Diagnostics, NeuMoDx developed the Quantitative BK virus (BKV) assay, which is intended to help clinical manage infection in the critical organ transplant patient population. The partnership strengthens the NeuMoDx transplant menu, which already includes tests with CE mark for Epstein–Barr virus and cytomegalovirus viral load monitoring for the management of immunocompromised patients, NeuMoDx said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.